These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Trans-cerebral electrophoresis of L-DOPA in the complex treatment of parkinsonism]. Neĭmark EZ; Evtushenko SK; Dukhovnaia MA Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(9):1334-8. PubMed ID: 6506979 [TBL] [Abstract][Full Text] [Related]
5. [Dystonia preceding dopa-responsive parkinsonism--heterogeneous clinical features]. Miwa H; Mizuno Y No To Shinkei; 1996 Feb; 48(2):149-54. PubMed ID: 8865694 [TBL] [Abstract][Full Text] [Related]
7. [Should L-dopa therapy for Parkinson's disease be started early or late? Clinical course of the major tetrad in 122 Parkinsonian patients treated with L-dopa over 14 years]. Indo T; Takahashi A Rinsho Shinkeigaku; 1987 Nov; 27(11):1419-22. PubMed ID: 3447802 [No Abstract] [Full Text] [Related]
8. [L-dopa/benserazide during pregnancy in a patient with juvenile parkinsonism]. Arai H; Shinotoh H; Hattori T Rinsho Shinkeigaku; 1997 Mar; 37(3):264-5. PubMed ID: 9217430 [TBL] [Abstract][Full Text] [Related]
9. [Results of L-dopa treatment in parkinsonism (author's transl)]. Kolasa M; Reichowa J; Bieniowa A Przegl Lek; 1976; 33(3):407-10. PubMed ID: 1273335 [No Abstract] [Full Text] [Related]
10. Long-term follow-up of early dopa treatment in Parkinson's disease. Markham CH; Diamond SG Ann Neurol; 1986 Apr; 19(4):365-72. PubMed ID: 3707088 [TBL] [Abstract][Full Text] [Related]
12. [Therapy of parkinsonism using L-Dopa (Brocadopa)]. Jörg J Med Welt; 1975 Jan; 26(3):124-6. PubMed ID: 1110622 [No Abstract] [Full Text] [Related]
13. [Effectiveness of slow release L-DOPA/benserazide in treatment of end-of-dose akinesia in Parkinson disease]. Eichhorn TE; Schrag A; Trenkwalder C; Selzer R; Kohnen R; Oertel WH; Poewe W Nervenarzt; 1995 Dec; 66(12):933-41. PubMed ID: 8584079 [TBL] [Abstract][Full Text] [Related]
14. [Onset-and end-of-dose dyskinesias induced by L-dopa treatment in a patient with juvenile parkinsonism]. Katsuki T; Shimizu N; Mizuno Y No To Shinkei; 1984 Dec; 36(12):1201-5. PubMed ID: 6529518 [TBL] [Abstract][Full Text] [Related]
15. [L-dopa effective parkinsonism appeared after shunt revision of the aqueductal stenosis: report of two cases]. Ochiai H; Yamakawa Y; Miyata S; Kawasoe T No To Shinkei; 2000 May; 52(5):425-9. PubMed ID: 10845212 [TBL] [Abstract][Full Text] [Related]
16. [The deterioration of patients with parkinsonism treated with L-dopa]. Guillard A Nouv Presse Med; 1975 Oct; 4(35):2503-6. PubMed ID: 1196872 [TBL] [Abstract][Full Text] [Related]
17. [The L-dopa test in Parkinson's disease]. Esteguy M; Bonnet AM; Kefalos J; Lhermitte F; Agid Y Rev Neurol (Paris); 1985; 141(5):413-5. PubMed ID: 4048732 [TBL] [Abstract][Full Text] [Related]
18. [Combined treatment of parkinsonism with L-dopa and Parkopan]. Lukasiewicz K Wiad Lek; 1977 May; 30(10):775-7. PubMed ID: 867994 [No Abstract] [Full Text] [Related]
20. [The combination of L-dopa and carbidopa in therapy of a case of familial juvenile parkinsonism]. Piccirilli M; Piccinin GL; La Medica A Clin Ter; 1981 Feb; 96(3):335-40. PubMed ID: 7307449 [No Abstract] [Full Text] [Related] [Next] [New Search]